RT Journal Article
SR Electronic
T1 Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002996
DO 10.1136/jitc-2021-002996
VO 9
IS 11
A1 Lonardi, Sara
A1 Prete, Alessandra Anna
A1 Morano, Federica
A1 Messina, Marco
A1 Formica, Vincenzo
A1 Corsi, Domenico Cristiano
A1 Orciuolo, Corrado
A1 Frassineti, Giovanni Luca
A1 Zampino, Maria Giulia
A1 Casagrande, Mariaelena
A1 Masi, Gianluca
A1 Ronzoni, Monica
A1 Scartozzi, Mario
A1 Buonadonna, Angela
A1 Mosconi, Stefania
A1 Ratti, Margherita
A1 Sartore-Bianchi, Andrea
A1 Tamburini, Emiliano
A1 Prisciandaro, Michele
A1 Bergamo, Francesca
A1 Spada, Massimiliano
A1 Corallo, Salvatore
A1 Vettore, Valentina
A1 Loupakis, Fotios
A1 Fassan, Matteo
A1 Del Bianco, Paola
A1 Zagonel, Vittorina
A1 Pietrantonio, Filippo
YR 2021
UL http://jitc.bmj.com/content/9/11/e002996.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.